Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 1 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Jaroline Pharma from Fosses-la-Ville, company number BE1023796101, closed financial year 2025 with a result of € -1,387 after tax. For that financial year Jaroline Pharma recorded a gross margin of € -915 and equity of € 3,613. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 24, 2026.
€ 3,613
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -1,387
Profit after tax over the fiscal year.
€ 4,036
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -1,387.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 529
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to Jaroline Pharma?
What happened at Jaroline Pharma in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 1,387. Source: NBB ↗
- New establishment in Fosses-la-Ville. KBO
- CELINE RUTH became a director. NBB
- Start of the company according to the CBE. KBO
A new publication or filing at Jaroline Pharma? We notify you, reason included.
Follow Jaroline PharmaDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Jaroline Pharma is CELINE RUTH. It owns 100% of Falipharma itself.
Directors
According to the 2025 annual accounts
CELINE RUTH
Director
since 2025
Establishments
Establishment units
Physical locations of this company
Rue Rauhisse, Vitrival 47
5070 Fosses-la-Ville
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1023.796.101
- VAT number
- BE 1023.796.101
- Registered office
- Rue Rauhisse, Vitrival 47, 5070 Fosses-la-Ville
- Names & denominations
- Jaroline Pharma
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 May 2025
- Peppol
- Active · Active since 3 Oct 2025
- Contact
- [email protected] +32478252415
- Activities · NACE
Activiteiten van holdings
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige zakelijke dienstverlening, neg